Genetic Mutations – Pop Quiz 10/7/2022
165761657616576
This condition is associated with mutations in which of the following?
A. Peptidyl arginine deiminase, type III (PADI3)
B. Copper-transporting-P-type ATPase 7A (ATP7A)
C. Keratin 81 (K81)
D. ATP-dependent DNA helicase (ERCC2)
E. Keratin 86 (K86)
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. …
This condition is associated with mutations in which of the following?
A. Peptidyl arginine deiminase, type III (PADI3)
B. Copper-transporting-P-type ATPase 7A (ATP7A)
C. Keratin 81 (K81)
D. ATP-dependent DNA helicase (ERCC2)
E. Keratin 86 (K86)
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. … 
Onychomycosis is an extremely common and difficult to treat condition. We have numerous oral and topical treatments in our therapeutic repertoire, but oral medication use is often limited by the risk of hepatotoxicity or drug interactions. Traditional topical lacquers, on the other hand, have limited efficacy due to their inability to adequately penetrate the nail plate. Efinaconazole is a newer t … 
Cosmopolitan recently posted an article, "Lasers for Acne Scars: How They Work and the Best Treatments to Try Right Now.” What can lasers do now for acne scars, and what developments are on the horizon?
For expert advice, I reached out to Dallas dermatologist DiAnne Davis, MD, FAAD, who will be part of a panel discussion on lasers and energy-based devices to treat acne scars at the ODAC D … 
Which of the following is a major criteria for the diagnosis of the below syndrome?
A. Bilamellar calcification of the falx cerebri
B. Macrocephaly
C. Medulloblastoma
D. Bilateral ovarian fibromas
E. Frontal bossing
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
The burden of psoriasis in patients with skin of color is significant, with reduced quality of life and often delayed diagnosis compared to patients with white skin. Andrew Alexis, MD, MPH, shares how he thinks learners will benefit from participating in this enduring educational activity from our symposium at the 2022 Skin of Color Update annual meeting in New York.
[/vc_column_text][/vc_colum … 